Cantourage Group (HIGH) Investor presentation summary

Investment highlights and market position

• Leading pan-European medical cannabis platform with profitable growth in regulated markets.

• Asset-light, scalable, and capital-efficient business model.

• Market leader in Germany, UK, and Poland, with plans for further European expansion.

• Diversified product portfolio addressing current and future patient needs.

Market trends and opportunities

• Rapidly growing European medical cannabis markets, driven by increasing patient demand.

• Over 150 million people in Europe suffer from sleep disorders, 60 million from anxiety, and 100 million from chronic pain.

• Medical cannabis adoption is expanding across multiple indications, including neurology, pain, and autoimmune conditions.

• Europe is expected to become the world's largest medical cannabis market, with potential upside from recreational legalization.

Business model and operational strengths

• Unique asset-light operating model enables profitable growth and flexibility.

• Global supply chain allows rapid onboarding of legal cultivators into EU markets.

• Telemedicine platforms in Germany and UK streamline patient access and prescription fulfillment.

• Revenue-sharing model with growers and a multi-brand strategy support a broad product offering.